ArticleAmerican health & drug benefits2016

Kyprolis (Carfilzomib) Received New Indications as Combination Therapy for Use in Relapsed and/or Refractory Multiple Myeloma.

Lisa A RaedlerPubMed ↗Full text ↗

No numbers read from the abstract.